跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
candidates
首页
药物
candidates
candidates
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)
EP 4056686 A1
申请人: CORNING INC
优先权: 2012
EP
US
10 件公开
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
EP 3515930 A1
申请人: US HEALTH
优先权: 2016
EP
US
WO
9 件公开
Use of cross-protection to identify novel vaccine candidates for infectious agents
US 7323180 B2
申请人: CA MINISTER NAT DEFENCE
优先权: 2004
US
7 件公开
CHIMERIC ANTIGEN RECEPTOR FOR TUMOR TARGETING
EP 4504799 A4
申请人: FATE THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
6 件公开
Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
EP 2468734 A1
申请人: SIEMENS MEDICAL SOLUTIONS
优先权: 2008
CN
EP
US
6 件公开
Vaccine candidates against Johne's disease
US 2007134274 A1
申请人: TALAAT ADEL M
优先权: 2006
US
6 件公开
Global gene regulators (GGR) as vaccine candidates against paratuberculosis
US 9663758 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2014
US
6 件公开
GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION
EP 3875112 A1
申请人: US HEALTH
优先权: 2012
EP
US
5 件公开
Methods for treating patients who are candidates for inhaled nitric oxide treatment
US 8795741 B2
申请人: INO THERAPEUTICS LLC
优先权: 2012
US
5 件公开
METHODS FOR DETERMINING DRUG CANDIDATES
EP 4428869 A1
申请人: MOSAIQUES DIAGNOSTICS & THERAPEUTICS AG
优先权: 2023
EP
US
WO
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈